Form D · Pharmaceuticals

AVENUE THERAPEUTICS, INC.

Bay Harbor Islands, FL · CIK 0001644963

Offering snapshot reported Feb 14, 2023 · SEC filing

Reported sold
$243K
Offering amount: $243K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 27, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 14, 2023Initial$242,537No comparison1SEC filing
Jan 12, 2017Initial$200,000No comparison3SEC filing

Offering details

Securities
Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$21.8K
Finders' fees
$0
Form D file number
021-473384

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Aegis Capital Corp.15007

Source: Form D, filed Feb 14, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Faith Charles Director
Neil Herskowitz Director
David J. Horin Executive
David Jin Executive
Jay Kranzler, M.D., Ph.D. Director
Lucy Lu, M.D. Director, Executive
Alexandra Mac Lean, M.D. Executive
Curtis Oltmans Director
Jeffrey Paley, M.D. Director
Scott A. Raines, M.D. Executive
Scott A. Reines, M.D., Ph.D. Executive
Lindsay A. Rosenwald, M.D. Director
Michael Ryan, M.S. Executive
Akhtar Samad, M.D. Ph.D. Director
Michael Weiss Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
1111 Kane Concourse, Suite 301
Bay Harbor Islands, FL, 33154